EHS
EHS

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic


  • World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int.

  • Marian, A. J. Current state of vaccine development and targeted therapies for COVID-19: Impact of basic science discoveries. Cardiovasc. Pathol. 50, 107278 (2021).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Monschein, T. et al. Vaccination and multiple sclerosis in the era of the COVID-19 pandemic. J. Neurol. Neurosurg. Psychiatry 92, 1033–1043 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Pawlitzki, M. et al. Merits and culprits of immunotherapies for neurological diseases in times of COVID-19. EBioMedicine 56, 102822 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Holmes, E. A. et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 7, 547–560 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kreps, S. et al. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Netw. Open 3, e2025594 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Park, C. L. et al. Americans’ COVID-19 stress, coping, and adherence to CDC guidelines. J. Gen. Intern. Med. 35, 2296–2303 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Taylor, S. et al. A proactive approach for managing COVID-19: The importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2. Front Psychol 11, 575950 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bell, S., Clarke, R., Mounier-Jack, S., Walker, J. L. & Paterson, P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine 38, 7789–7798 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Reiter, P. L., Pennell, M. L. & Katz, M. L. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?. Vaccine 38, 6500–6507 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ochel, P., Eitze, S., Seufert, A. & Betsch, C. Ergebnisse aus dem COVID-19 Snapshot MOnitoring COSMO, Längsschnitt Thüringen, Erhebung 1-3: Zwischenstand der aktuellen Lage. https://projekte.uni-erfurt.de/cosmo2020/files/COSMO_TH_W3.pdf.

  • Bendau, A., Plag, J., Petzold, M. B. & Ströhle, A. COVID-19 vaccine hesitancy and related fears and anxiety. Int. Immunopharmacol. 97, 107724 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Moiola, L., Rommer, P. S. & Zettl, U. K. Prevention and management of adverse effects of disease modifying treatments in multiple sclerosis. Curr. Opin. Neurol. 33, 286–294 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Rommer, P. S. et al. Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry. Mult Scler. 25, 1641–1652 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Winkelmann, A., Loebermann, M., Reisinger, E. C., Hartung, H.-P. & Zettl, U. K. Disease-modifying therapies and infectious risks in multiple sclerosis. Nat Rev Neurol 12, 217–233 (2016).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Wang, L., Wang, F.-S. & Gershwin, M. E. Human autoimmune diseases: A comprehensive update. J. Intern. Med. 278, 369–395 (2015).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Primers 4, 43 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Reich, D. S., Lucchinetti, C. F. & Calabresi, P. A. Multiple Sclerosis. N. Engl. J. Med. 378, 169–180 (2018).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Thompson, A. J., Baranzini, S. E., Geurts, J., Hemmer, B. & Ciccarelli, O. Multiple sclerosis. Lancet 391, 1622–1636 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Haji Akhoundi, F., Sahraian, M. A. & Naser Moghadasi, A. Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients. Mult Scler. Relat. Disord. 41, 102164 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Patejdl, R., Penner, I. K., Noack, T. K. & Zettl, U. K. Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration. Autoimmun. Rev. 15, 210–220 (2016).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Patejdl, R. & Zettl, U. K. Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions. Autoimmun. Rev. 16, 925–936 (2017).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Akmatov, M. K., Holstiege, J., Steffen, A. & Bätzing, J. Vaccination against seasonal influenza infection among chronically ill individuals—An analysis of outpatient claims data from 2009 to 2018. Versorgungsatlas Report 20, 1–20 (2020).


    Google Scholar
     

  • Ehde, D. M., Roberts, M. K., Herring, T. E. & Alschuler, K. N. Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States. Mult Scler. Relat. Disord. 49, 102788 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Serrazina, F., Sobral Pinho, A., Cabral, G., Salavisa, M. & Correia, A. S. Willingness to be vaccinated against COVID-19: An exploratory online survey in a Portuguese cohort of multiple sclerosis patients. Mult Scler. Relat. Disord. 51, 102880 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Borah, P. et al. Perspectives on RNA vaccine candidates for COVID-19. Front. Mol. Biosci. 8, 635245 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Soiza, R. L., Scicluna, C. & Thomson, E. C. Efficacy and safety of COVID-19 vaccines in older people. Age Age. 50, 279–283 (2021).

    Article 

    Google Scholar
     

  • Winkelmann, A., Loebermann, M., Barnett, M., Hartung, H.-P. & Zettl, U. K. Vaccination and immunotherapies in neuroimmunological diseases. Nat. Rev. Neurol. 18, 289–306 (2022).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zrzavy, T. et al. Vaccination in multiple sclerosis: Friend or foe?. Front. Immunol. 10, 1883 (2019).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Neumann-Böhme, S. et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur. J. Health Econ. 21, 977–982 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wise, J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ 372, n699 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • de Lima, A. B., Paes, R. A. & Alvarenga, R. M. P. Personality factors in recently diagnosed multiple sclerosis patients: A preliminary investigation with the NEO-FFI scale. Arq. Neuropsiquiatr. 73, 200–204 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162–173 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Heidler, F. et al. Vaccination setting of patients with autoimmune diseases in times of severe acute respiratory syndrome coronavirus type 2 pandemic using the example of multiple sclerosis patients: A longitudinal multicenter study. ENE 85, 104–111 (2022).

    CAS 

    Google Scholar
     

  • German Standing Committee on Vaccination (STIKO). Immunisation Schedule. https://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Downloads-Impfkalender/Impfkalender_Englisch.pdf?__blob=publicationFile.

  • Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33, 1444–1444 (1983).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Cloninger, C. R., Svrakic, D. M. & Przybeck, T. R. A psychobiological model of temperament and character. Arch. Gen. Psychiatry 50, 975–990 (1993).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Brewin, C. R. et al. Brief screening instrument for post-traumatic stress disorder. Br. J. Psychiatry 181, 158–162 (2002).

    Article 
    PubMed 

    Google Scholar
     

  • Quintana, J. M. et al. Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 107, 216–221 (2003).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Schwartz, E. S., Chapman, B. P., Duberstein, P. R., Weinstock-Guttman, B. & Benedict, R. H. B. The NEO-FFI in Multiple Sclerosis: Internal consistency, factorial validity, and correspondence between self and informant reports. Assessment 18, 39–49 (2011).

    Article 
    PubMed 

    Google Scholar
     

  • Schmitz, N., Hartkamp, N., Baldini, C., Rollnik, J. & Tress, W. Psychometric properties of the German version of the NEO-FFI in psychosomatic outpatients. Pers. Individ. Differ. 31, 713–722 (2001).

    Article 

    Google Scholar
     

  • Xiang, X. M. et al. COVID-19 vaccination willingness among people with multiple sclerosis. Mult Scler. J. Exp. Transl. Clin. 7, 205521732110171 (2021).


    Google Scholar
     

  • Graeber, D., Schmidt-Petri, C. & Schröder, C. Attitudes on voluntary and mandatory vaccination against COVID-19: Evidence from Germany. PLoS ONE 16, e0248372 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • McAteer, J., Yildirim, I. & Chahroudi, A. The VACCINES Act: Deciphering vaccine hesitancy in the time of COVID-19. Clin. Infect. Dis. 71, 703–705 (2020).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Deutsches Ärzteblatt. Pfizer rechnet mit Milliardenumsatz durch Coronaimpfstoff. https://www.aerzteblatt.de/nachrichten/128712/Pfizer-rechnet-mit-Milliardenumsatz-durch-Coronaimpfstoff.

  • Deutsches Ärzteblatt. Biontech erwirtschaftet beträchtlichen Nettogewinn. https://www.aerzteblatt.de/nachrichten/128908/Biontech-erwirtschaftet-betraechtlichen-Nettogewinn.

  • Fisher, K. A. et al. Attitudes toward a potential SARS-CoV-2 vaccine: A survey of U.S. adults. Ann. Intern. Med. 173, 964–973 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Saeed, S. et al. Knowledge, attitude and practice towards COVID-19 among individuals with associated comorbidities. J. Med. Life 14, 225–237 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Green, M. S., Abdullah, R., Vered, S. & Nitzan, D. A study of ethnic, gender and educational differences in attitudes toward COVID-19 vaccines in Israel—Implications for vaccination implementation policies. Isr. J. Health Policy Res. 10, 26 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chiaravalloti, N. D. et al. The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis. J. Neurol. 268, 1598–1607 (2021).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Vogel, A. C., Schmidt, H., Loud, S., McBurney, R. & Mateen, F. J. Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study. Mult Scler. Relat. Disord. 46, 102512 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ozamiz-Etxebarria, N., Idoiaga Mondragon, N., Dosil Santamaría, M. & Picaza Gorrotxategi, M. Psychological symptoms during the two stages of lockdown in response to the COVID-19 outbreak: An investigation in a sample of citizens in Northern Spain. Front. Psychol. 11, 1491 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Özdin, S. & Bayrak Özdin, Ş. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int. J. Soc. Psychiatry 66, 504–511 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • El-Far Cardo, A., Kraus, T. & Kaifie, A. Factors that shape people’s attitudes towards the COVID-19 pandemic in Germany—The influence of MEDIA, politics and personal characteristics. Int. J. Environ. Res. Public Health 18, 7772 (2021).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wadman, M. Journal retracts paper claiming COVID-19 vaccines kill. Science 373, 147 (2021).

    ADS 
    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Wadman, M. The overlooked superpower of mRNA vaccines. Science 373, 479 (2021).

    ADS 
    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Thacker, P. D. Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial. BMJ 375, n2635 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Singanayagam, A. et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(21)00648-4 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Male, V. Menstrual changes after covid-19 vaccination. BMJ 374, n2211 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Paul-Ehrlich-Institut—Coronavirus und COVID-19—Sicherheit von COVID-19-Impfstoffen. https://www.pei.de/DE/newsroom/dossier/coronavirus/arzneimittelsicherheit.html.



  • Source link

    EHS
    Back to top button